Piza F, Schemper M
Abteilung für Transplantation, I. Chirurgischen Universitätsklinik, Wien.
Wien Klin Wochenschr. 1988 Jan 8;100(1):12-6.
The influence of match, immunological therapy, age of the recipient and sex has been analysed by graft survival in 91 patients receiving a second kidney graft. Effects of these risk factors in first kidney grafts are not demonstrable in second grafts with the exception of cyclosporin which also produces better second graft survival. The main active risk factor for second transplants is endurance of function of the first graft. Function of the first graft over a period exceeding 1 year gives a significantly better second graft survival rate than function lasting less than one year.
通过对91例接受第二次肾移植患者的移植物存活情况进行分析，研究了配型、免疫治疗、受者年龄和性别等因素的影响。除环孢素外，这些危险因素对首次肾移植的影响在第二次移植中并不明显，环孢素也能提高第二次移植的存活率。第二次移植的主要活性危险因素是首次移植物的功能耐久性。首次移植物功能超过1年的患者，其第二次移植物存活率显著高于功能持续时间不足1年的患者。
